Seven Year Update on SOC-1702: A Phase 2 Study Using Trabectedin (T) in Combination with Ipilimumab (I), Nivolumab (N) and Trabectedin (T) in Previously Untreated Patients with Advanced Soft Tissue Sarcoma.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined